Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
Go back to Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 -0.71 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.92 | 52 Week High | $37.39 | |||
| Open | $25.58 | 52 Week Low | $28.25 | |||
| Day High | $25.36 | P/E | 15.28 | |||
| Day Low | $24.94 | EPS | $1.65 | |||
| Volume | 119,614,341 | |||||
| Puritan Financial Group, Inc. (AMEX: TNG) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $0.01 | 52 Week Low | $0.01 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $0.00 | |||
| Volume | 0 | |||||
